Literature DB >> 31685715

Monitoring of Antithrombotic Therapy.

Masako Yamazaki1.   

Abstract

Entities:  

Year:  2019        PMID： 31685715      PMCID： PMC7113145          DOI： 10.5551/jat.ED120

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  14 in total

1.  A microchip flow-chamber system for quantitative assessment of the platelet thrombus formation process.

Authors:  Kazuya Hosokawa; Tomoko Ohnishi; Masashi Fukasawa; Taro Kondo; Hisayo Sameshima; Takehiko Koide; Kenichi A Tanaka; Ikuro Maruyama
Journal:  Microvasc Res       Date:  2011-12-06       Impact factor: 3.514

2.  Influences of hemodilution and anticoagulation on antiplatelet P2Y12 therapy: in vitro whole blood perfusion model.

Authors:  Satoru Ogawa; Kazuya Hosokawa; Kenichi A Tanaka
Journal:  J Cardiothorac Vasc Anesth       Date:  2013-10-03       Impact factor: 2.628

3.  Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.

Authors:  M Yamazaki; T Ohnishi; K Hosokawa; K Yamaguchi; T Yoneyama; A Kawashima; Y Okada; K Kitagawa; S Uchiyama
Journal:  J Thromb Haemost       Date:  2016-08-03       Impact factor: 5.824

4.  Haemodilution-induced changes in coagulation and effects of haemostatic components under flow conditions.

Authors:  S Ogawa; T Ohnishi; K Hosokawa; F Szlam; E P Chen; K A Tanaka
Journal:  Br J Anaesth       Date:  2013-06-20       Impact factor: 9.166

5.  Studies of a microchip flow-chamber system to characterize whole blood thrombogenicity in healthy individuals.

Authors:  Yusuke Yamaguchi; Takanori Moriki; Atsuko Igari; Yumiko Matsubara; Tomoko Ohnishi; Kazuya Hosokawa; Mitsuru Murata
Journal:  Thromb Res       Date:  2013-06-16       Impact factor: 3.944

6.  Assessment of platelet-derived thrombogenicity with the total thrombus-formation analysis system in coronary artery disease patients receiving antiplatelet therapy.

Authors:  Y Arima; K Kaikita; M Ishii; M Ito; D Sueta; Y Oimatsu; K Sakamoto; K Tsujita; S Kojima; K Nakagawa; S Hokimoto; H Ogawa
Journal:  J Thromb Haemost       Date:  2016-02-19       Impact factor: 5.824

7.  Analysing responses to aspirin and clopidogrel by measuring platelet thrombus formation under arterial flow conditions.

Authors:  Kazuya Hosokawa; Tomoko Ohnishi; Hisayo Sameshima; Naoki Miura; Takashi Ito; Takehiko Koide; Ikuro Maruyama
Journal:  Thromb Haemost       Date:  2012-11-22       Impact factor: 5.249

8.  Total Thrombus-Formation Analysis System can Predict 1-Year Bleeding Events in Patients with Coronary Artery Disease.

Authors:  Tatsuro Mitsuse; Koichi Kaikita; Masanobu Ishii; Yu Oimatsu; Nobuhiro Nakanishi; Miwa Ito; Yuichiro Arima; Daisuke Sueta; Satomi Iwashita; Koichiro Fujisue; Hisanori Kanazawa; Seiji Takashio; Satoshi Araki; Hiroki Usuku; Satoru Suzuki; Kenji Sakamoto; Eiichiro Yamamoto; Hirofumi Soejima; Kenichi Tsujita
Journal:  J Atheroscler Thromb       Date:  2019-08-08       Impact factor: 4.928

9.  Total Thrombus-Formation Analysis System (T-TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation.

Authors:  Miwa Ito; Koichi Kaikita; Daisuke Sueta; Masanobu Ishii; Yu Oimatsu; Yuichiro Arima; Satomi Iwashita; Aya Takahashi; Tadashi Hoshiyama; Hisanori Kanazawa; Kenji Sakamoto; Eiichiro Yamamoto; Kenichi Tsujita; Megumi Yamamuro; Sunao Kojima; Seiji Hokimoto; Hiroshige Yamabe; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

10.  Total Thrombus-formation Analysis System Predicts Periprocedural Bleeding Events in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Authors:  Yu Oimatsu; Koichi Kaikita; Masanobu Ishii; Tatsuro Mitsuse; Miwa Ito; Yuichiro Arima; Daisuke Sueta; Aya Takahashi; Satomi Iwashita; Eiichiro Yamamoto; Sunao Kojima; Seiji Hokimoto; Kenichi Tsujita
Journal:  J Am Heart Assoc       Date:  2017-04-24       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.